Trevena, Inc.
US ˙ OTCPK ˙ US89532E2081

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Francois Nader. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Francois Nader reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:MRNA / Moderna, Inc. Director 32,781
US:TALS / Talaris Therapeutics Inc Director 386,932
US:XLRN / Acceleron Pharma Inc Director 0
US:US00C4W3Z001 / Alexion Pharmaceuticals, Inc. Director 0
Director 0
US:BXLT / Baxalta Incorporated Director 0
US:TRVN / Trevena, Inc. Director 8,870
US:NPSP / NPS Pharmaceuticals Inc President, CEO and Director, Director 0
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Francois Nader. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas TRVN / Trevena, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em TRVN / Trevena, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

TRVN / Trevena, Inc. Insider Trades
Vendas Internas TRVN / Trevena, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em TRVN / Trevena, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

TRVN / Trevena, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Francois Nader conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2026-05-04 2026-04-30 4 MRNA Moderna, Inc.
Common Stock
M - Exercise 12,174 32,781 59.08
2022-09-13 2022-07-25 4/A TALS Talaris Therapeutics, Inc.
Common Stock
J - Other 138,500 386,932 55.75
2022-09-13 2022-07-25 4/A TALS Talaris Therapeutics, Inc.
Common Stock
J - Other -138,500 0 -100.00
2022-09-13 2022-07-21 4/A TALS Talaris Therapeutics, Inc.
Common Stock
P - Purchase 36,500 138,500 35.78 3.72 135,780 515,220
2022-09-13 2022-07-21 4/A TALS Talaris Therapeutics, Inc.
Common Stock
J - Other 248,432 248,432
2022-09-13 2022-07-21 4/A TALS Talaris Therapeutics, Inc.
Common Stock
J - Other -248,432 147,255 -62.78
2022-09-13 2022-07-20 4/A TALS Talaris Therapeutics, Inc.
Common Stock
P - Purchase 52,000 102,000 104.00 3.62 188,240 369,240
2022-09-13 2022-07-19 4/A TALS Talaris Therapeutics, Inc.
Common Stock
P - Purchase 50,000 50,000 3.52 176,000 176,000
2022-07-25 2022-07-25 4 TALS Talaris Therapeutics, Inc.
Common Stock
J - Other 138,500 386,932 55.75
2022-07-25 2022-07-25 4 TALS Talaris Therapeutics, Inc.
Common Stock
J - Other -138,500 0 -100.00
2022-07-25 2022-07-21 4 TALS Talaris Therapeutics, Inc.
Common Stock
P - Purchase 36,500 138,500 35.78 3.72 135,780 515,220
2022-07-25 2022-07-21 4 TALS Talaris Therapeutics, Inc.
Common Stock
J - Other 248,432 248,432
2022-07-25 2022-07-21 4 TALS Talaris Therapeutics, Inc.
Common Stock
J - Other -248,432 87,735 -73.90
2022-07-25 2022-07-20 4 TALS Talaris Therapeutics, Inc.
Common Stock
P - Purchase 52,000 102,000 104.00 3.62 188,240 369,240
2022-07-25 2022-07-19 4 TALS Talaris Therapeutics, Inc.
Common Stock
P - Purchase 50,000 50,000 3.52 176,000 176,000
2022-05-12 2022-05-10 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -23,100 16,620 -58.16
2022-05-12 2022-05-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale -3,196 20,607 -13.43 136.10 -434,976 2,804,613
2022-05-12 2022-05-10 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 23,100 23,803 3,285.92 18.87 435,897 449,163
2022-05-02 2022-04-28 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 5,415 5,415
2022-05-02 2022-04-28 4 MRNA Moderna, Inc.
Restricted Stock Units
M - Exercise -703 0 -100.00
2022-05-02 2022-04-28 4 MRNA Moderna, Inc.
Common Stock
M - Exercise 703 703
2021-12-16 2021-12-15 4 TALS Talaris Therapeutics, Inc.
Common Stock
G - Gift -59,520 336,167 -15.04
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -3,222 0 -100.00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -8,185 0 -100.00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -7,500 0 -100.00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -20,000 0 -100.00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -576 0 -100.00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -7,500 0 -100.00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -10,000 0 -100.00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -10,000 0 -100.00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -7,500 0 -100.00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Common Stock
U - Other -6,749 0 -100.00
2021-07-23 2021-07-21 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
D - Sale to Issuer -13,921 0 -100.00
2021-05-24 2021-05-20 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 673 13,921 5.08
2021-05-24 2021-05-20 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 1,962 13,248 17.38
2021-05-06 3 TALS Talaris Therapeutics, Inc.
Common Stock
395,687
2021-04-30 2021-04-28 4 MRNA Moderna, Inc.
Restricted Stock Units
A - Award 703 703
2021-04-30 2021-04-28 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 4,081 4,081
2021-02-02 2021-01-29 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 3,222 3,222
2021-02-02 2021-01-29 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1,622 6,749 31.64
2021-01-26 2021-01-22 4 PRVL Prevail Therapeutics Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -17,000 0 -100.00
2021-01-26 2021-01-22 4 PRVL Prevail Therapeutics Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -32,000 0 -100.00
2021-01-26 2021-01-22 4 PRVL Prevail Therapeutics Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -133,447 0 -100.00
2021-01-26 2021-01-22 4 PRVL Prevail Therapeutics Inc.
Common Stock
U - Other -23,747 0 -100.00
2020-06-19 2020-06-17 4 PRVL Prevail Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 17,000 17,000
2020-05-18 2020-05-14 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 941 11,286 9.10
2020-05-18 2020-05-14 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 3,468 10,345 50.43
2020-04-30 2020-04-29 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 18,270 18,270
2020-01-24 2020-01-22 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 8,185 8,185
2020-01-24 2020-01-22 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1,377 5,127 36.72
2019-12-11 2019-12-10 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 17,889 17,889 18.87 337,565 337,565
2019-12-11 2019-12-10 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 39,720 39,720 18.87 749,516 749,516
2019-06-25 2019-06-24 4 PRVL Prevail Therapeutics Inc.
Series B Preferred Stock
C - Conversion -23,747 0 -100.00
2019-06-25 2019-06-24 4 PRVL Prevail Therapeutics Inc.
Common Stock
C - Conversion 23,747 23,747
2019-05-17 2019-05-15 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 2,726 6,877 65.67
2019-01-29 2019-01-25 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7,500 7,500
2019-01-29 2019-01-25 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1,250 3,750 50.00
2018-05-11 2018-05-09 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 2,174 4,151 109.96
2018-03-05 2018-03-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7,500 7,500
2018-03-05 2018-03-01 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1,250 2,500 100.00
2017-11-30 2017-11-29 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 1,977 1,977
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7,500 7,500
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1,250 1,250
2016-06-07 2016-06-03 4 BXLT Baxalta Inc
Stock Option (Right to Buy)
D - Sale to Issuer -5,960 0 -100.00
2016-06-07 2016-06-03 4 BXLT Baxalta Inc
Common Stock, $0.01 par value
D - Sale to Issuer -7,657 0 -100.00
2016-05-12 2016-05-10 4 BXLT Baxalta Inc
Common Stock, $0.01 par value
A - Award 4,500 7,657 142.54
2016-03-07 2016-03-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 10,000 10,000
2015-07-29 2015-07-27 4 BXLT Baxalta Inc
Stock Option (Right to Buy)
A - Award 5,960 5,960
2015-07-29 2015-07-27 4 BXLT Baxalta Inc
Common Stock, par value $0.01 per share
A - Award -3,140 3,140 -50.00
2015-05-21 2015-05-20 4 TRVN TREVENA INC
Stock Option (Right to Buy)
A - Award 8,870 8,870
2015-04-08 2015-04-06 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 10,000 10,000
2015-04-08 2015-01-08 4/A XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 576 576
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Performance Units
D - Sale to Issuer -115,432 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Performance Units
D - Sale to Issuer -27,926 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -24,302 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -19,598 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -80,912 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -109,602 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -82,826 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -67,636 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -154,284 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -133,125 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -104,438 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -196,018 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -106,643 0 -100.00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
U - Other -276,955 0 -100.00 46.00 -12,739,930
2015-02-20 2015-02-13 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -24,301 24,302 -50.00
2015-02-20 2015-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -12,600 276,955 -4.35 45.88 -578,088 12,706,695
2015-02-20 2015-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 24,301 289,555 9.16
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -9,798 19,598 -33.33
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 80,912 80,912
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -653 106,643 -0.61
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -3,262 104,438 -3.03
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -24,466 191,534 -11.33
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -5,625 67,636 -7.68
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -4,943 265,254 -1.83 45.85 -226,637 12,161,896
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 9,798 270,197 3.76
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 653 260,399 0.25 38.27 24,990 9,965,470
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 3,262 259,746 1.27 8.21 26,781 2,132,515
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 24,466 256,484 10.54 3.34 81,716 856,657
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 5,625 232,018 2.48 3.25 18,281 754,058
2015-02-20 2015-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -7,263 226,393 -3.11 45.85 -333,009 10,380,119
2015-02-20 2015-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
J - Other 20,301 233,656 9.52
2015-01-09 2015-01-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 576 576
2014-12-12 2014-12-11 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 20,000 20,000
2014-05-15 2014-05-14 4 TRVN TREVENA INC
Stock Option (Right to Buy)
A - Award 8,870 8,870
2014-04-18 2014-02-12 4 NPSP NPS PHARMACEUTICALS INC
Performance Units
A - Award 40,500 40,500
2014-02-14 2014-02-13 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -24,301 48,603 -33.33
2014-02-14 2014-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -11,767 233,656 -4.79 38.30 -450,676 8,949,025
2014-02-14 2014-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 24,301 245,423 10.99
2014-02-14 2014-02-12 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 29,396 29,396
2014-02-14 2014-02-12 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
A - Award 107,296 107,296
2014-02-11 2014-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -7,258 221,122 -3.18 35.13 -254,974 7,768,016
2014-02-11 2014-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
J - Other 20,300 228,380 9.76
2014-01-31 2014-01-30 4 TRVN TREVENA INC
Stock Option (Right to Buy)
A - Award 17,741 17,741
2014-01-30 3 TRVN TREVENA INC
Common Stock
0
2014-01-09 2014-01-07 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
A - Award 20,250 216,000 10.34
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -16,739 73,261 -18.60
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -10,398 109,602 -8.66
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -5,850 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -4,500 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -3,150 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -5,746 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -4,875 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -3,750 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -2,625 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -9,030 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -2,771 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -2,308 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -1,775 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -1,243 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -64,356 0 -100.00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 16,739 226,936 7.96 3.25 54,402 737,542
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 10,398 210,197 5.20 5.71 59,373 1,200,225
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 5,850 199,799 3.02 6.16 36,036 1,230,762
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 4,500 193,949 2.38 5.85 26,325 1,134,602
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 3,150 189,449 1.69 5.05 15,908 956,717
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 5,746 186,299 3.18 3.60 20,686 670,676
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 4,875 180,553 2.77 3.93 19,159 709,573
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 3,750 175,678 2.18 4.10 15,375 720,280
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 2,625 171,928 1.55 4.42 11,602 759,922
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 9,030 169,303 5.63 4.13 37,294 699,221
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 2,771 160,273 1.76 4.31 11,943 690,777
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 2,308 157,502 1.49 4.37 10,086 688,284
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 1,775 155,194 1.16 4.50 7,988 698,373
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 1,243 153,419 0.82 4.07 5,059 624,415
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 64,356 152,176 73.28 5.73 368,760 871,968
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -9,800 82,826 -10.58
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -16,650 5,850 -74.00
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -17,008 4,500 -79.08
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -43,458 87,820 -33.10 32.36 -1,406,118 2,841,486
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 9,800 131,278 8.07 5.71 55,958 749,597
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 16,650 121,478 15.88 6.16 102,564 748,304
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 17,008 104,828 19.37 5.85 99,497 613,244
2013-09-30 2013-09-26 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -992 21,508 -4.41
2013-09-30 2013-09-26 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -19,350 3,150 -86.00
2013-09-30 2013-09-26 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -6,497 87,820 -6.89 33.60 -218,299 2,950,752
2013-09-30 2013-09-26 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -143,503 94,317 -60.34 33.07 -4,745,644 3,119,063
2013-09-30 2013-09-26 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 992 237,820 0.42 5.85 5,803 1,391,247
2013-09-30 2013-09-26 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 19,350 236,828 8.90 5.05 97,718 1,195,981
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -54,000 54,000 -50.00
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -16,754 5,746 -74.46
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -58,231 0 -100.00
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -148,367 217,478 -40.55 11.68 -1,732,526 2,539,556
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 54,000 365,845 17.32 3.34 180,360 1,221,922
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 16,754 311,845 5.68 3.60 60,314 1,122,642
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 58,231 295,091 24.58 3.85 224,189 1,136,100
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -41,769 58,231 -41.77
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -13,875 4,875 -74.00
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -15,000 3,750 -80.00
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -79,356 0 -100.00
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -150,000 236,860 -38.77 11.27 -1,689,840 2,668,370
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 41,769 386,860 12.10 3.85 160,811 1,489,411
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 13,875 345,091 4.19 3.93 54,529 1,356,208
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 15,000 331,216 4.74 4.10 61,500 1,357,986
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 79,356 316,216 33.50 4.29 340,437 1,356,567
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -15,358 79,356 -16.22
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -16,125 2,625 -86.00
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -55,470 9,030 -86.00
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -6,104 2,771 -68.78
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -6,567 2,308 -73.99
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -7,100 1,775 -80.00
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -7,632 1,243 -85.99
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -35,644 64,356 -35.64
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -150,000 236,860 -38.77 11.01 -1,650,795 2,606,715
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 15,358 386,860 4.13 4.29 65,886 1,659,629
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 16,125 371,502 4.54 4.42 71,272 1,642,039
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 55,470 355,377 18.50 4.13 229,091 1,467,707
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 6,104 299,907 2.08 4.31 26,308 1,292,599
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 6,567 293,803 2.29 4.37 28,698 1,283,919
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 7,100 287,236 2.53 4.50 31,950 1,292,562
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 7,632 280,136 2.80 4.07 31,062 1,140,154
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 35,644 272,504 15.05 5.73 204,240 1,561,448
2013-02-21 2013-02-19 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -50,000 50,000 -50.00
2013-02-21 2013-02-19 4 NPSP NPS PHARMACEUTICALS INC
Common stock
F - Taxes -21,624 236,126 -8.39 8.01 -173,208 1,891,369
2013-02-21 2013-02-19 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 50,000 257,750 24.07
2013-02-15 2013-02-13 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 72,904 72,904
2013-02-15 2013-02-13 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
A - Award 196,018 196,018
2013-02-11 2013-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common stock
F - Taxes -7,193 207,750 -3.35 8.61 -61,932 1,788,728
2013-02-11 2013-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
J - Other 20,299 214,943 10.43
2012-12-26 2012-12-21 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -11,068 154,043 -6.70 9.10 -100,719 1,401,791
2012-12-21 2012-12-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
A - Award 108,000 108,000
2012-02-09 2012-02-07 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
A - Award 107,700 107,700
2012-02-09 2012-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
A - Award 60,900 60,900
2012-02-09 2012-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
A - Award 60,900 60,900
2012-02-01 2012-01-20 4 NPSP NPS PHARMACEUTICALS INC
Options (right to buy)
A - Award 46,313 46,313
2012-02-01 2012-01-30 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
A - Award 54,000 54,000
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)